ArticleClinical and translational allergy2013

Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients.

Juliane Rieker-Schwienbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.